The Discounted Cash Flow (DCF) valuation of Anika Therapeutics Inc (ANIK) is 4.11 USD. With the latest stock price at 10.81 USD, the upside of Anika Therapeutics Inc based on DCF is -61.9%.
Based on the latest price of 10.81 USD and our DCF valuation, Anika Therapeutics Inc (ANIK) is a sell. selling Anika stocks now will result in a potential gain of 61.9%.
| Range | Selected | |
| WACC / Discount Rate | 4.7% - 6.4% | 5.5% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | 3.63 - 10.81 | 4.11 |
| Upside | -66.4% - -0.0% | -61.9% |